The discrepancies in published research could be related to the features of carnitine pharmacokinetic
Ethics statement The studies involving humans were approved by Ethics Committee of the National Institute of Childrens diseases and the Faculty of Medicine, Comenius University Bratislava (20 March 2013)
Int J Colorectal Dis 14:1828 Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C et al (2000) Butyrate inhibits inflammatory responses through NFB inhibition: implications for Crohns disease
For patients on bupropion, this conservative approach has merit because it reduces the likelihood of severe GI side effects that could lead to the dehydration and electrolyte imbalances that increase seizure risk
Food and Drug Administration (FDA) regulatory route